Rocco Capuano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rocco Capuano has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Gallo
Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania “Luigi Vanvitelli”, Naples, Italy
6 shared publications - Alvino Bisecco
Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
5 shared publications - Gioacchino Tedeschi
First Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
5 shared publications - Manuela Altieri
Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
4 shared publications - Alessandro D'AMbrosio
Department of Advanced Medical and Surgical Sciences, and 3T MRI-Center, University of Campania ‘Luigi Vanvitelli’ , Naples 80138
3 shared publications - Gabriella Santangelo
Department of Psychology, University of Campania “Luigi Vanvitelli”, Caserta, Italy
2 shared publications
Latest Publications
- 24 July 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 113, 107401
Asymptomatic spinal cord lesions in Multiple Sclerosis: A systematic review and meta-analysis of subclinical disease activity
- 24 July 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 113, 107401
Asymptomatic spinal cord lesions in Multiple Sclerosis: A systematic review and meta-analysis of subclinical disease activity
- 27 December 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (6) , 2807-2810
Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis
Introduction Lymphopenia is a known side effect of dimethyl fumarate (DMF), a disease-modifying therapy (DMT) for patients with multiple sclerosis (pwMS). A body mass index ≥ 30 kg/m2 has been identified as a protective factor; however, no data are available on lymphopenia in pwMS undergoing to weight loss due to bariatric surgery. Methods We described two pwMS with history of bariatric surgery who started DMF as DMT. Results The two pwMS experienced persistent lymphopenia during DMF-treatment, which was resolved after its discontinuation. Conclusions Several mechanisms might modify DMF pharmacokinetic profiles after bariatric surgery and its bioavailability. Absolute lymphocyte count should be monitored in pwMS treated with DMF and history of bariatric surgery and weight loss.
- 27 December 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (6) , 2807-2810
Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis
Introduction Lymphopenia is a known side effect of dimethyl fumarate (DMF), a disease-modifying therapy (DMT) for patients with multiple sclerosis (pwMS). A body mass index ≥ 30 kg/m2 has been identified as a protective factor; however, no data are available on lymphopenia in pwMS undergoing to weight loss due to bariatric surgery. Methods We described two pwMS with history of bariatric surgery who started DMF as DMT. Results The two pwMS experienced persistent lymphopenia during DMF-treatment, which was resolved after its discontinuation. Conclusions Several mechanisms might modify DMF pharmacokinetic profiles after bariatric surgery and its bioavailability. Absolute lymphocyte count should be monitored in pwMS treated with DMF and history of bariatric surgery and weight loss.
- 25 March 2022
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 61, 103774
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis
- 25 March 2022
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 61, 103774
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis
- Open Access
- 8 October 2021
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 429, 118163
Psychological consequences of COVID-19 pandemic on people with multiple sclerosis: A meta-analytic study
- 8 October 2021
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 429, 118163
Open AccessPsychological consequences of COVID-19 pandemic on people with multiple sclerosis: A meta-analytic study
- 1 October 2021
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 429, 118183
Do differences in educational attainment measures impact on the assessment of cognitive performance in multiple sclerosis?
- 1 October 2021
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 429, 118183
Do differences in educational attainment measures impact on the assessment of cognitive performance in multiple sclerosis?
- Open Access
- 7 June 2021
- Published by Hindawi Limited in Journal of Nutrition and Metabolism
- Vol. 2021, 1-8
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population
Background. Vitamin D (25(OH)D) deficiency is a prevalent condition worldwide. However, the highest prevalence rates of 25(OH)D deficiency have been attributed to regions with higher latitude. A close association between 25(OH)D and cardio-cerebrovascular (CCV) risk factors and major health problems has been identified. Aim. To establish the prevalence of 25(OH)D deficiency and to investigate the relationship between 25(OH)D levels and CCV risk factors (blood cholesterol, triglycerides, glucose concentrations, body mass index, and systolic and diastolic blood pressure) in a cohort representative of Southern Italy. Methods. The prevalence of 25(OH)D levels was evaluated in 1200 subjects aged 2574 years (600 males and 600 females), enrolled in the VIP (from Italian for Irno Valley Prevention) Project, whereas multiple linear regression analysis was used to determine the relationship between 25(OH)D levels and CCV risk factors. Results. Only 13.3 of females and 11.1 of males showed adequate serum concentrations of 25(OH)D (30ng/ml), while 59.3 of females and 55.1 of males showed 25(OH)D deficient levels (Conclusions. We report a high prevalence of 25(OH)D deficiency across the largest Italian adult population studied so far and, in particular, the first across Southern Italy; furthermore, we provide data on the association between 25(OH)D deficiency and higher CCV risk factors.
- 7 June 2021
- Published by Hindawi Limited in Journal of Nutrition and Metabolism
- Vol. 2021, 1-8
Open AccessEpidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population
Background. Vitamin D (25(OH)D) deficiency is a prevalent condition worldwide. However, the highest prevalence rates of 25(OH)D deficiency have been attributed to regions with higher latitude. A close association between 25(OH)D and cardio-cerebrovascular (CCV) risk factors and major health problems has been identified. Aim. To establish the prevalence of 25(OH)D deficiency and to investigate the relationship between 25(OH)D levels and CCV risk factors (blood cholesterol, triglycerides, glucose concentrations, body mass index, and systolic and diastolic blood pressure) in a cohort representative of Southern Italy. Methods. The prevalence of 25(OH)D levels was evaluated in 1200 subjects aged 2574 years (600 males and 600 females), enrolled in the VIP (from Italian for Irno Valley Prevention) Project, whereas multiple linear regression analysis was used to determine the relationship between 25(OH)D levels and CCV risk factors. Results. Only 13.3 of females and 11.1 of males showed adequate serum concentrations of 25(OH)D (30ng/ml), while 59.3 of females and 55.1 of males showed 25(OH)D deficient levels (Conclusions. We report a high prevalence of 25(OH)D deficiency across the largest Italian adult population studied so far and, in particular, the first across Southern Italy; furthermore, we provide data on the association between 25(OH)D deficiency and higher CCV risk factors.
- Open Access
- 1 January 2021
- Published by SAGE Publications in Therapeutic Advances in Neurological Disorders
- Vol. 14
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
- 1 January 2021
- Published by SAGE Publications in Therapeutic Advances in Neurological Disorders
- Vol. 14
Open AccessHumoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab